ArticleProceedings of the National Academy of Sciences of the United States of America2024

Cell cycle plasticity underlies fractional resistance to palbociclib in ER+/HER2- breast tumor cells.

Tarek M Zikry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.